Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia.

Name: Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia.
Author: Malkan, Umit Y

Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia. — المؤلف: Malkan, Umit Y — Open medicine (Warsaw, Poland) 2019

المؤلف: Malkan, Umit Y
النشر: Open medicine (Warsaw, Poland) 2019
الوصف: 22-24 p.